BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18431284)

  • 1. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.
    Becker KL; Snider R; Nylen ES
    Crit Care Med; 2008 Mar; 36(3):941-52. PubMed ID: 18431284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization.
    Snider RH; Nylen ES; Becker KL
    J Investig Med; 1997 Dec; 45(9):552-60. PubMed ID: 9444882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.
    Nylen ES; Whang KT; Snider RH; Steinwald PM; White JC; Becker KL
    Crit Care Med; 1998 Jun; 26(6):1001-6. PubMed ID: 9635646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoneutralization of procalcitonin or its component peptides: a promising treatment of sepsis.
    Becker KL
    Clin Sci (Lond); 2010 Dec; 119(12):515-7. PubMed ID: 20649514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
    Becker KL; Snider R; Nylen ES
    Br J Pharmacol; 2010 Jan; 159(2):253-64. PubMed ID: 20002097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin used as a marker of infection in the intensive care unit.
    Ugarte H; Silva E; Mercan D; De Mendonça A; Vincent JL
    Crit Care Med; 1999 Mar; 27(3):498-504. PubMed ID: 10199528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1.
    Gérard Y; Hober D; Assicot M; Alfandari S; Ajana F; Bourez JM; Chidiac C; Mouton Y; Bohuon C; Wattre P
    J Infect; 1997 Jul; 35(1):41-6. PubMed ID: 9279723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Infection and plasma procalcitonin].
    Yukioka H
    Clin Calcium; 2005 Mar; 15(3):152-7. PubMed ID: 15741695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating procalcitonin and cleavage products in septicaemia compared with medullary thyroid carcinoma.
    Ittner L; Born W; Rau B; Steinbach G; Fischer JA
    Eur J Endocrinol; 2002 Dec; 147(6):727-31. PubMed ID: 12457446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin has bioactivity at calcitonin receptor family complexes: potential mediator implications in sepsis.
    Sexton PM; Christopoulos G; Christopoulos A; Nylen ES; Snider RH; Becker KL
    Crit Care Med; 2008 May; 36(5):1637-40. PubMed ID: 18434892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late immunoneutralization of procalcitonin arrests the progression of lethal porcine sepsis.
    Martinez JM; Wagner KE; Snider RH; Nylen ES; Muller B; Sarani B; Becker KL; White JC
    Surg Infect (Larchmt); 2001; 2(3):193-202; discussion 202-3. PubMed ID: 12593709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin and proinflammatory cytokine interactions in sepsis.
    Whang KT; Vath SD; Becker KL; Snider RH; Nylen ES; Muller B; Li Q; Tamarkin L; White JC
    Shock; 2000 Jul; 14(1):73-8. PubMed ID: 10909897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Procalcitonin. A new diagnostic parameter for severe infections and sepsis].
    Oberhoffer M; Karzai W; Meier-Hellmann A; Reinhart K
    Anaesthesist; 1998 Jul; 47(7):581-7. PubMed ID: 9740932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.
    Redman RS; Kerr GS; Payne JB; Mikuls TR; Huang J; Sayles HR; Becker KL; Nylén ES
    Biotech Histochem; 2016; 91(2):77-85. PubMed ID: 26800284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procalcitonin for detecting medullary thyroid carcinoma: a systematic review.
    Trimboli P; Seregni E; Treglia G; Alevizaki M; Giovanella L
    Endocr Relat Cancer; 2015 Jun; 22(3):R157-64. PubMed ID: 25934688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin as a diagnostic marker in patients with aspiration after closed head injury.
    Pusch F; Wildling E; Freitag H; Weinstabl C
    Wien Klin Wochenschr; 2001 Sep; 113(17-18):676-80. PubMed ID: 11603102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue.
    Linscheid P; Seboek D; Nylen ES; Langer I; Schlatter M; Becker KL; Keller U; Müller B
    Endocrinology; 2003 Dec; 144(12):5578-84. PubMed ID: 12960010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin for the clinical laboratory: a review.
    Schneider HG; Lam QT
    Pathology; 2007 Aug; 39(4):383-90. PubMed ID: 17676478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin in bacterial infections--hype, hope, more or less?
    Christ-Crain M; Müller B
    Swiss Med Wkly; 2005 Aug; 135(31-32):451-60. PubMed ID: 16208582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.